Transactions
9
Insider / ANGIODYNAMICS INC
Clemmer James C
President and CEO at ANGIODYNAMICS INC
- Company
- ANGIODYNAMICS INC
- Ticker
- ANGO
- First filing on record
- October 9, 2025
- Latest trade on record
- July 22, 2026
- SEC filings
- EDGAR ↗
Clemmer James C, President and CEO at ANGIODYNAMICS INC, has disclosed 9 transactions in ANGO since October 9, 2025: 1 purchase (1 open-market buy) and 6 sales, worth about $1.1M at the reported prices. The latest was filed July 24, 2026, 2 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
1
Sales
6
Avg. disclosure lag
2.2d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Clemmer James C made no purchases and 6 sales worth $999K, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Clemmer James C has traded 1 stock on record; the largest by dollars is ANGO.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 6 | 72,439 | $999K |
| M | Option exercise or conversion | 2 | 236,719 | — |
| P | Open-market purchase | 1 | 10,000 | $112K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 8 | 0 | 6 · $999K |
| 2025 | 1 | 1 · $112K | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ANGO | Option / conversion M | July 22, 2026 | July 24, 2026 | 2d | 184,361 | — | — | derivative | Form 4 ↗ | |
| ANGO | Sell F | July 22, 2026 | July 24, 2026 | 2d | 26,728 | $14 | $369K | Form 4 ↗ | ||
| ANGO | Option / conversion M | July 22, 2026 | July 24, 2026 | 2d | 52,358 | — | — | Form 4 ↗ | ||
| ANGO | Sell F | July 20, 2026 | July 21, 2026 | 1d | 4,223 | $14 | $58K | Form 4 ↗ | ||
| ANGO | Sell F | July 19, 2026 | July 21, 2026 | 2d | 487 | $14 | $6,579 | Form 4 ↗ | ||
| ANGO | Sell F | July 19, 2026 | July 21, 2026 | 2d | 11,764 | $14 | $159K | Form 4 ↗ | ||
| ANGO | Sell F | July 17, 2026 | July 21, 2026 | 4d | 10,649 | $14 | $144K | Form 4 ↗ | ||
| ANGO | Sell F | July 16, 2026 | July 21, 2026 | 5d | 18,588 | $14 | $263K | late | Form 4 ↗ | |
| ANGO | Buy P | October 9, 2025 | October 9, 2025 | 0d | 10,000 | $11 | $112K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 24, 2026 | Form 4 | 0001140361-26-029633 | 3 | published | EDGAR ↗ |
| July 21, 2026 | Form 4 | 0001140361-26-029178 | 5 | published | EDGAR ↗ |
| October 9, 2025 | Form 4 | 0001140361-25-037836 | 1 | published | EDGAR ↗ |
Other insiders at ANGIODYNAMICS INC
- Nighan Warren JR SVP Quality and Regulatory 9 rows
- Trowbridge Stephen A EVP and CFO 9 rows
- Campbell Chad Thomas SVP/GM, Vascular Access 8 rows
- Piccinini Laura SVP International 8 rows
- Weiss Lawrence T SVP, Chief Legal Officer 4 rows
- Auen Eileen O'Shea Director 1 row
- Burgess Lorinda Director 1 row
- DONNELLY HOWARD W Director 1 row
- JOHNSON WESLEY Director 1 row
- Licitra Karen A Director 1 row
Everyone on file, with contracts and lobbying under the company's name: ANGIODYNAMICS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 9 | October 9, 2025 | July 24, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.